Filter by content type
Filter by content year
Filter by form group
Filter by type
Filter by tags
Filter by gallery
Filter by category
Filter by category
Filter by category
Filter by category
Biogen Reports 2016 Revenues of $11.4 Billion
January 26, 2017 - … of this release. “Biogen seeks to advance transformational pipeline programs for some of the greatest challenges in … and plans; potential of our commercial business and pipeline programs; clinical trials and data readouts; … of this release. “Biogen seeks to advance transformational pipeline programs for some of the greatest challenges in …
Biogen Completes Separation of Global Hemophilia Business, Bioverativ
February 1, 2017 - … and the potential of Biogen’s commercial business and pipeline programs. These forward-looking statements may be … and the potential of Biogen’s commercial business and pipeline programs. These forward-looking statements may be … and the potential of Biogen’s commercial business and pipeline programs. These forward-looking statements may be …
Biogen Licenses Phase 2 Anti-Tau Antibody from Bristol-Myers Squibb
April 13, 2017 - … be a leader in Alzheimer’s disease and we are building a pipeline with multiple approaches to address the complex, … palsy.” The addition of BMS-986168 to Biogen’s pipeline signifies both a broader commitment to rare … millions of patients and families. With an expanded AD pipeline that includes a range of anti-tau and anti-amyloid …
Biogen Reports First Quarter 2017 Revenues of $2.8 Billion
April 25, 2017 - … “Furthermore, we continued to build our neurology pipeline with the anticipated addition of our new Phase … and plans; potential of our commercial business and pipeline programs; clinical trials and data readouts and … “Furthermore, we continued to build our neurology pipeline with the anticipated addition of our new Phase …
Biogen Announces Management Change
June 13, 2017 - … success. Biogen has a rich portfolio of products and pipeline and can look forward to even greater success under … success. Biogen has a rich portfolio of products and pipeline and can look forward to even greater success under … success. Biogen has a rich portfolio of products and pipeline and can look forward to even greater success under …
Biogen Appoints Catherine Steele Senior Vice President of Corporate Affairs
June 28, 2017 - … Executive Officer Michel Vounatsos. “As we strengthen our pipeline, reaffirm our commitment to neuroscience and look to … Executive Officer Michel Vounatsos. “As we strengthen our pipeline, reaffirm our commitment to neuroscience and look to … Executive Officer Michel Vounatsos. “As we strengthen our pipeline, reaffirm our commitment to neuroscience and look to …
Alisha A. Alaimo Appointed SVP of Biogen’s US Therapeutic Operations
July 24, 2017 - … from across the company’s late-stage neuroscience pipeline. She will report directly to Chief Executive Officer … from across the company’s late-stage neuroscience pipeline. She will report directly to Chief Executive Officer … from across the company’s late-stage neuroscience pipeline. She will report directly to Chief Executive Officer …
Biogen Reports Record Quarterly Revenues of $3.1 Billion, Raises Full Year Revenue Guidance
July 25, 2017 - … quarter demonstrated our ability to advance and expand the pipeline, deliver strong commercial results, and build our … therapies. And, we have added exciting assets to our pipeline to drive future growth.” Vounatsos continued, “We … to invest in and build an industry leading neuroscience pipeline. With an overarching goal of being the world’s …
Biogen Appoints Anabella Villalobos Senior Vice President, Biotherapeutic & Medicinal Sciences
July 31, 2017 - … activities and potential of our commercial business and pipeline programs. These forward-looking statements may be … activities and potential of our commercial business and pipeline programs. These forward-looking statements may be … activities and potential of our commercial business and pipeline programs. These forward-looking statements may be …
Biogen Appoints Camille Lee as SVP, Alzheimer’s Disease Therapeutic Area
September 25, 2017 - … the potential of Biogen’s commercial business and pipeline programs, , and the expected benefits from Ms. Lee’s … the potential of Biogen’s commercial business and pipeline programs, , and the expected benefits from Ms. Lee’s … the potential of Biogen’s commercial business and pipeline programs, , and the expected benefits from Ms. Lee’s …
Pagination
- Page 1
- Next page ››